Evidence Series ā Investigator and Molecular testing
Evidence Series ā Investigator and Molecular testing
Evidence Investigator | Adaptable, Efficient & Comprehensive
The Evidence Investigator is a compact, semi-automated benchtop analyser that offers efficient and comprehensive testing across a range of applications including clinical diagnostics, molecular, research, toxicology and food diagnostics.
Renowned for its versatility, robustness and effective reporting methods, the Evidence Investigator has been used in a wide range of laboratory settings for over 15 years. This highly advanced yet simple to use analyser has only one moving part, giving the user peace of mind.
The Evidence Investigator contains a host of innovative on-board data analysis features ensuring manual processes are kept to a minimum.
By utilising the same multiplex technology as the other Evidence Series analysers, the Evidence Investigator can process up to 44 results from a single sample, with a maximum throughput of up to 2376 tests per hour. Offering efficiency without compromising on accuracy, the Evidence Investigator is the perfect fit for medium throughput laboratories seeking maximum use of bench space.
Molecular Testing
Our molecular product range offers diagnostic, prognostic and predictive solutions across a variety of disease areas including sexually transmitted infection (STI), Respiratory tract infection, colorectal cancer, familial hypercholesterolemia (FH) and cardiovascular disease (CVD). Additionally, we can provide a wide range of assay formats including single nucleotide polymorphisms (SNP) genotyping, pathogen detection and mutation detection.
Pathogen Detection
STI and Respiratory Arrays
Both arrays detect the most common and frequently requested infections in sexual and respiratory health. These comprehensive, highly sensitive and specific tests enable identification of co-infections simultaneously, often in asymptomatic patients and enable antibiotic stewardship.
Mutation Detection
KRAS, BRAF, PIK3CA array and Familial Hypercholesterolemia Arrays I & II
These unique biochip assays permit high discrimination between multiple targets in a number of genes with a rapid turnaround time (3 hours). The arrays enable detection of the most frequently occurring mutations known to cause disease (FH) and adversely affect patient treatment (KRAS, BRAF, PIK3CA). A unique primer set is designed for each target which will hybridise to a complimentary oligo-nucleotide probe spotted on a biochip discrete test region (DTR).
SNP Genotyping
Cardiovascular Risk Prediction Array
This array identifies individuals with a genetic predisposition to coronary heart disease (CHD). The innovative multiplex primers are designed to discriminate DNA sequences which differ only at one base.
For more information on our Evidence Series or Molecular range of Assays, contact us at EvidenceSeries@randox.com
We Are Randox | BANDOXās dĆ©but performance at Randox FEST 2018
Thanks to our series of We Are Randox staff profiles, we have the opportunity to find out more about our colleagues, and one of our favourite things is when we discover a lesser-known talent, hobby or interest. From top bakers to renowned athletes, dedicated volunteers to inspiring youth leaders, and charity fundraisers to creative artists, many of our staff are just as busy outside of the office as they are in it.
This month, in the search for our next We Are Randox interviewee, we’ve been lucky enough to find not one but five humble musicians working in our midst!
The newly-formed Randox staff band, or BANDOX as they are known to those of us here at Randox, made up of drummer Suzanne Alexander, Rhythm Guitarist Jeremy Parker, Bass Guitarist Scott McKeown, Lead Guitarist Max Brown, and Vocalists Sally Picton and Rebecca Aldous, recently made their début performance at our annual staff fun day, Randox FEST.
After playing an entertaining setlist of both classical and modern musical anthems including Sweet Caroline, Sweet Home Alabama, and Livin’ On A Prayer, for which they received a gallant round of applause and even demands for an encore, the band sat down with us to tell us a little bit more about themselves and to share some interesting anecdotes.
Drummer Suzanne Alexander
Suzanne is an experienced brass player, drummer and percussionist, having played at a number of gigs over the years as part of a brass band and impressively also a céilí band. Suzanne also got married this year. Congratulations Suzanne!
Rhythm Guitarist Jeremy Parker
Jeremy is the newest member of BANDOX, having only joined the group 2 days before their exclusive Randox FEST performance! Not only does Jeremy play guitar in another band called ‘Chivalry is Dead’, but he also plays the trumpet. Something you may not know about Jeremy however – he has been known to preach the odd sermon!
Bass Guitarist Scott McKeown
Matched only by his flair for colourful and bold shirt choices, R&D Product Manager Scott’s skills on the bass guitar have seen him play in rock concerts across the country. The best-dressed member of the Randox Biosciences team, Scott is always ready for a rave.
Lead Guitarist Max Brown
Max is well-known throughout the Randox office for his creativity in our Graphic Design team. Less well-known however, unless you follow him on Instagram, are his skills on the electric guitar. Fun fact about Max – he once had a trial with Sunderland Athletic Football Club while at university but suffered fallen arches and had to withdraw.
Vocalists Sally Picton and Rebecca Aldous
Sally and Rebecca are no strangers to the mic, having performed around the world with the Belfast Philharmonic Choir, for which the well-oiled singing duo’s favourite songs to sing are those by ABBA. Rebecca has a bassoon called Bob and Sally used to be a rugby referee.
So there you have it – our staff band! BANDOX will be coming soon to a Randox event near you, so keep an eye out on our social media channels for live performances and exclusive interviews.
For autograph requests or further information, please email randoxpr@randox.com
Randox Northern Ireland Potato Festival returns to Giant’s Causeway
Northern Ireland’s favourite potato-themed festival is back, bigger and better than ever, on Saturday 13th October 2018. And the popular event is set for a boost thanks to a new partnership with headline sponsor Randox, and a festival cookery theatre compered by NI Food Ambassador Paula McIntyre MBE.
Set against the backdrop of the world-famous Giant’s Causeway, the Randox Northern Ireland Potato Festival is a heady mix of family fun, a celebration of world-renowned potato breeder John Clarke, and a chance to sample the delights of the agri-food industry which thrives in the Causeway Coast & Glens. Festival fun starts at 10am and runs until 5pm in the grounds of the Causeway Hotel.
Now in its 6th year, the line-up for Festival Day boasts a packed programme of activities and attractions for all ages, and there is no admission fee.
Festival Committee Chairman Michael McKillop, Glens of Antrim Potatoes, said;
“This year the committee has worked effortlessly to bring a bigger and better potato festival to the North Antrim coast on the site of the Giant’s Causeway. We have more fun-filled events planned with loads of arts and crafts on site and fantastic local chefs doing cookery demos. Along with a free open day to the Causeway Centre, it will be a great family day out.”
“I would like to extend my thanks to the National Trust for their continued support. Every year the National Trust is a key partner and sponsor for the Potato Festival, not only opening up the Giant’s Causeway site and providing the perfect location but giving their staff to co-ordinate the activities on the day. They also coincide the festival with their free Community Open Day welcoming everyone to enjoy their Visitor Experience and award winning guided tours for free providing a great opportunity to showcase Northern Ireland’s heritage to local and international visitors while celebrating the legacy of John Clarke.”
This year also sees the first appearance of the Naturally North Coast and Glens Artisan Market, with a popular collection of award-winning local artisan food and drink, and hand-made colourful art and crafts.
The Food NI Roadshow is back with its festival cookery theatre, compered by NI Food Ambassador and newly-honoured local chef Paula McIntyre MBE, and featuring a selection of talented homegrown chefs and producers.
Q Radio Bus and the PSNI tractor are making their debuts in the event’s exhibitor area, with a new ‘Kidzone’ featuring bouncy castles, potato-inspired activity workshops, ‘The Mighty Spud’, balloon-modelling, face-painting and a petting farm.
And for potato enthusiasts there will be a series of specialist talks on a range of topics including John Clarke and breeding your own potato varieties, as well as an exhibition of all John’s varieties.
Cutting Edge Helicopters will be back in the air again offering spectacular helicopter sightseeing flights (fee applies), and on the eve of Festival Day (Friday 12th October) a ‘Super Spud Tour’ will be held along the beautiful Causeway Coastal Route, celebrating the area’s unique potato breeding and growing heritage.
This ticketed tour, offered by Causeway Coast Foodie Tours, will include a potato producer tour, themed lunch and an opportunity to enjoy a delicious cocktail featuring Ireland’s first potato-distilled vodka.
Randox Founder and Managing Director, Dr. Peter FitzGerald, said;
“This sponsorship means a great deal to Randox and we are delighted to work, for the first time, alongside the dedicated and enthusiastic committee behind this fantastic event. The local community has played a significant role in the successes of Randox over the past number of years and we believe it is important to give the same support and encouragement back wherever we can.
“The Randox Northern Ireland Potato Festival is well-known in the area and attracts an impressive number of visitors, from both near and far. Like the Randox Northern Ireland Potato Festival, we at Randox are dedicated to supporting local quality produce, evidenced in our production of meats, jams, chutneys and apple juice straight from Dundarave Estate in Bushmills and CherryValley Estate in Antrim. The food and hospitality industry in Northern Ireland is among the best in the world and we are pleased to help showcase award-winning local producers on a national platform.”
As well as Randox as the main sponsor, the festival has benefited from financial help from The National Trust, Glens of Antrim Potatoes, Causeway Coast & Glens Borough Council, NI Regional Food Programme (DAERA), Jamison Potatoes, McCurdy Potatoes, Wilsons Country, Manor Fresh, Active Packaging and Food NI.
The Randox Northern Ireland Potato Festival is a free event held in the region known and respected for the strength of the agricultural industry, award-winning food and drink and stunning scenery. Festival day coincides with the National Trust free open day at The Giant’s Causeway Visitor Centre (Saturday only).
There will be a free park-and-ride service operating from Bushmills car park and from Dunluce School.
For more information about the Randox Northern Ireland Potato Festival, please contact the Randox PR team by emailing randoxpr@randox.com
Why choose hair for drug and alcohol testing?
A hair drugs test offers a longer window of detection than alternative testing and provides a detailed month-on-month view and an overall picture of drug use. This can highlight trends of drug use, suggest abstinence or show evidence of use depending on the length of the hair sample.
When a drug is taken it is absorbed into the blood stream and circulated around the body. As a result, it is incorporated into the hair follicle meaning that as the hair grows, drugs are transferred into the hair strand. It can take up to 2 weeks for drug components to enter the hair and therefore analysis of a 3cm sample is recommended.
Randox Testing Services offer a combined analysis for hair alcohol testing as an aid in the determination of chronic excessive alcohol consumption. A combination test of alcohol markers ethyl glucuronide (EtG) and fatty acid ethyl esters (FAEE) help provide evidence to assess chronic excessive alcohol consumption but cannot be used to demonstrate abstinence of alcohol consumption.
This testing method is commonly used by employers for pre-employment screening which is an increasingly common type of workplace drug and alcohol testing. It forms an essential part of a company’s recruitment process. Hair testing is also heavily used in substance abuse assessment in child protection cases.
Body hair can be used to provide an extended window of up to 1 year of drug use.
Randox Testing Services
At Randox Testing Services we provide drug and alcohol testing to all professional bodies within the medico-legal sector and all workplaces from any industry. Through utilising innovative multiplex drug and alcohol screening methods as well as LC/GC mass spectrometry confirmatory analysis our complete service guarantees reliable and accurate results.
Our hair drug test along with all other testing services are flexible and can be tailored to our customer needs with a choice of testing methods. We offer a comprehensive drugs of abuse test menu and our service also includes expert witness reporting where applicable.
To get in touch with one of our experts about hair drug testing contact testingservices@randox.com or call +44 (0) 161 741 2760.
Think you may have Coeliac Disease? We have a test for that.
It’s just one of those things. Some of us simply can’t process gluten.
But what you may not know is that it may be coeliac disease that’s causing your bloating, headaches, discomfort or tiredness.
Coeliac disease is a genetic, autoimmune digestive disorder thought to affect 1 in 100 people worldwide. When someone with coeliac disease accidentally eats food containing gluten, it triggers an immune response. This causes the lining of the small intestine to become inflamed and damaged.
This is painful and makes it difficult for the body to absorb nutrients and vitamins from the food. For that reason, those with coeliac disease are advised to avoid all gluten completely. If not treated, coeliac disease can lead to other serious health problems such as osteoporosis, bowel cancer, and can cause infertility.
The good news is, that with Randox Health’s specialised Coeliac Autoimmune Disease test, you can find out whether you’re likely to be gluten-intolerant or have Coeliac disease.
The Coeliac Disease test is included in our Everyman, Everywoman and Signature programmes, and within our Digestive Health Programme, which is on offer during the month of September for only £200 (RRP £300).
Finding out you are gluten-intolerant can then be easily managed, with a wide variety of non-gluten alternatives for pasta, bread, cereal, biscuits and many other foods that usually contain gluten.
Why not book your Digestive Health Programme with Randox Health today and take back control of your health?
Visit www.randoxhealth.com or get in contact with our team by phoning 0800 2545 130.
September focus: Infection
Throughout the month of September, we will be highlighting on our social media channels how the Randox clinical range can help combat infections and infectious diseases through accurate and swift diagnosis, allowing the necessary steps to be taken in order to improve individual health.
What is infection?
Infection is the infiltration of an organism’s body tissues by disease-causing agents, their multiplication, and the reaction of host tissues to the infectious agents and toxins they produce. Infectious disease can also be known as communicable disease and transmissible disease.
How is the Randox helping to diagnose infection?
The Randox portfolio comprises of a wide range of products to combat infections including the RX series’ dedicated infectious disease testing panel, diagnostic reagents such as copper, potassium and sTfR and an extensive QC range catering for infectious disease testing in both liquid and lyophilised formats.
How can I limit my risk of contracting infection?
- The most important way to reduce the spread of infection is to wash your hands regularly with soap and water
- If you have an infection, get the appropriate vaccine and do not take antibiotics when they are not needed. This will only increase antibiotic-resistance
- Stay at home if you are sick to limit the spread of infection
- Use single-use tissues and dispose of them immediately after use
- Do not share cups, glasses or cutlery
- Do not touch your eyes, nose or mouth as viruses can transfer from your hands and in to the body
How can my workplace limit the spread of infection?
- Have an infection control plan
- Provide clean hand washing facilities
- Offer alcohol-based hand sanitisers when regular facilities are not available
- Provide boxes of single-use tissues and encourage their use
- Remind staff not to share cups, glasses or cutlery
- Remove newspapers and magazines from waiting areas
- Encourage staff to regularly disinfect their workspaces
- Make sure ventilation systems are working properly
For more information on how Randox is helping to diagnose infection, visit www.randox.com/infections.
Assessing the risk of developing Alzheimer’s disease
World Alzheimer’s Month
World Alzheimer’s Month is a global campaign to raise awareness and highlight the challenge that surrounds the disease, hosted by the Alzheimer’s disease International (ADI) every September. During this month World Alzheimer’s Day also takes place, 21 September each year.
47 million people are living with Alzheimer’s worldwide, costing 604 billion USD per year. This number is expected to rise to 76 million people with the disease by 2030.1 The FDA have not approved a medication for the treatment of Alzheimer’s disease since 2003. More than 400 clinical trials are currently looking at new treatments for Alzheimer’s disease (AD) and many of them are actively recruiting. Many still regard the amyloid hypothesis as a key explanation for Alzheimers disease development and progression.2
Alzheimer’s risk
Alzheimer’s disease is not necessarily inherited as a single-gene mutation as the inheritance pattern is incredibly complex. Unlike familial Alzheimer’s disease, a multi-gene form usually affects those aged 65 and older. The gene with the greatest known effect on the risk of developing late-onset Alzheimer’s disease is called apolipoprotein E (APOE). It is found on chromosome 19 and the APOE protein plays a role in handling fats in the body, including cholesterol. 3
ApoE plays a key role in lipid metabolism and the scientific and medical community recognise it as one of the most powerful genetic risk factors for dementia and other neurodegenerative diseases. It has become one of the most widely studied gene variants in Alzheimer’s disease and constitutes a major consideration for preventive medicine.
ApoE exists in three common isoforms (ApoE2, ApoE3 and ApoE4) which are coded by three co-dominant alleles (e2, e3, e4). As such, six common ApoE phenotypes exist within the general population: E2/E2, E3/E3, E4/E4 (homozygous) and E2/E3, E2/E4, E3/E4 (heterozygous). Medical professionals recognise the presence of the ApoE4 isoform as a major genetic risk factor for development of Alzheimer’s disease. Therefore, the availability of analytical methods for rapid and reliable ApoE4 classification is advantageous.
Evidence Investigator
The Apolipoprotein E4 (ApoE4) Array is a research use only product developed for the Evidence Investigator. The ApoE4 Array measures both total ApoE protein levels and ApoE4 protein levels directly from plasma samples and using a ratio can classify patients as negative or positive for ApoE4. In turn we can then assess their risk for the development of Alzheimer’s disease.
2-plex Biochip Array
- Pan ApoE
- ApoE4
An individual’s ApoE status has been shown to affect pre-symptomatic risk, diagnosis, prognosis, and treatment response for a variety of diseases, in particular Alzheimer’s disease. The ApoE4 Array can rapidly and accurately detect an individual’s ApoE4 status directly from a plasma sample. In combination with medical and family history, medication and lifestyle, this can deliver valuable information for personalised medicine approaches.
The 2-plex diagnostic Alzheimer’s test has the utility to detect the likelihood of a person’s chance of developing the disease to assist in the research and development of a potential drug to combat or slow down the process of Alzheimer’s.
1 https://www.alz.org/global/overview.asp
2 https://www.brightfocus.org/alzheimers/article/clinical-trials-alzheimers-disease-whats-new
For further information about the Randox Alzheimer’s Array, please email info@randoxbiosciences.com
The Evidence Series
Having developed the patented Biochip Array Technology following £250 million investment in research and development, we needed a platform that allowed Biochip Array Technology capabilities to be showcased. Step forward the Evidence Series.
The series includes the Evidence, the Evidence Evolution, the Evidence Investigator and the Evidence MultiSTAT. Each analyser has been designed and built with boundary pushing engineering, to ensure financial, labour and time savings for the end user.
Have a read below of the overview of each analyser in the Evidence Series
Evidence Evolution
The world’s first fully automated random-access biochip testing platform, the Evidence Evolution is the world’s most advanced immunoanalyser. With the capability to process up to 2,640 tests per hour, the Evidence Evolution offers complete system integration, as well as the most comprehensive test menu on the market.
Evidence
As the world’s first Biochip Array Technology system, the Evidence immunoanalyser has revolutionised laboratory screening worldwide. With the capability to process 3,960 tests per hour and a sample capacity of 360, the Evidence is ideal for use in a high throughput laboratory.
Evidence Investigator
The Evidence Investigator is a compact, semi-automated benchtop immunoanalyser that offers efficient and comprehensive testing across a range of applications including clinical diagnostics, molecular, toxicology and food diagnostics. The Evidence Investigator boasts a throughput of up to 2,376 tests per hour, offering efficiency without compromising on accuracy.
Evidence MultiSTAT
The Evidence MultiSTAT is a fully automated immunoanalyser that enables on-site simultaneous detection of up to 44 analytes from a single sample of oral fluid, urine or blood. With a three-step process and results generated in less than 20 minutes, the Evidence MultiSTAT is an ideal solution for those with no knowledge of laboratory procedures and offers a throughput of up to 132 tests per hour.
About the Randox Evidence Series
The Evidence Series is set to revolutionise diagnostic testing forever. Offering unrivalled capabilities across all analysers, we truly believe that the Evidence Series range of immunoassay analysers can meet your diagnostic testing capabilities.
For more information on any of the Evidence Series analysers, please visit https://www.randox.com/evidence-series/ or contact us evidenceseries@randox.com.
Randox Toxicology: Highest Percentage of Class A Drug Use in over a Decade
Figures released by the Home Office from the Crime Survey of England and Wales for 2017/2018 showed an 8.4 percent rise in 16-24 year olds using Class A drugs in the last year, compared to 7 percent in 2016/2017. As drugs are becoming more readily available due to the Dark Web, mobile phones and drug gangs, a broader network of distribution has been established and the price of cocaine has fallen.
Cocaine is a strong stimulant that comes in a powder (known as coke), freebase or crack form. With short lived effects, cocaine temporarily speeds up the mind and body. Freebase is a powder cocaine that has been prepared for smoking, whilst crack cocaine comes in a rock form. As both forms of cocaine can be smoked, they reach the brain quicker and have a stronger effect than powder cocaine. Injecting any form of the drug has serious risks including, damaged veins and the spread of blood-borne viruses, such as HIV and Hepatitis C. High doses of cocaine can cause the body temperature to rise, resulting in convulsions, a heart attack and heart failure.
The Telegraph recently reported that the fall in cocaine prices has now led to the highest number of young people using Class A drugs in over a decade, a rise from 4.8 percent in 2012/2013. The United Nation’s 2018 World Drug Report states that the street price for a gram of cocaine in the UK in 2016 was £41, the cheapest figure documented at the time since 1990. Compare this to cocaine prices in 2007 when it was £69 per gram.
“Our young people’s services have seen a significant rise in the use of Class A drugs”. Yasmin Batliwala, chair of London based drug and alcohol treatment charity WDP commented on the issue, “The primary drug of choice has always been alcohol, as well as cannabis, but certainly in the last two or more years the use of Class A drugs has increased substantially.” When cocaine and alcohol have been mixed it can cause particularly dangerous side effects and produce a toxic chemical called cocaethylene.
We have the Solution!
Randox Toxicology’s universally available patented Biochip Array Technology boasts cutting-edge multiplex testing capabilities, providing rapid and accurate drug detection from a single sample. Offering excellent cross-reactivity and unrivalled limits of detection, Biochip Array Technology’s intra and inter assay precision is typically <10% giving excellent correlation with confirmatory methods.
Persistently staying ahead of the ever-changing trends, Randox Toxicology are first to market with a range of tests for drugs of abuse, including the cocaine metabolite Benzoylecgonine (BZG). Utilising our Biochip Array Technology, Randox Toxicology’s DoA I, DoA I+, DoA ULTRA/DUID, DoA Evolution and DoA MultiSTAT panels all detect Benzoylecgonine.
Built on a foundation of continuous innovation, our research and development team continue to advance the future of toxicology through pioneering technology and novel tests. Offering the most advanced screening technology on the market, Randox Toxicology has transformed the landscape of drugs of abuse testing forever.
If you would like to find out more information on our unrivalled toxicology test menu, email us at info@randoxtoxicology.com or visit www.randoxtoxicology.com
Randox Food Diagnostics: Feed Testing in the Meat Industry ā Challenges and Solutions
The global meat industry is a multi-billion-dollar business contributing over $85 billion to the US economy alone annually. Globally it is valued at $800 billion and as such, it is one of the biggest industries in the world.
With its already strong position and an ever growing demand for meat products the market shows no sign of slowing down. There are continued demands set on producers to provide not only more meat, but meat at a higher quality. Public awareness on issues such as drug residues, animal rights, food safety and antibiotic resistance is on the rise and as such producers and processors are more and more required to meet stringent requirements.
With the increasing demand on quantity and quality the industry faces many challenges and one the key areas of interest in this production chain is the monitoring of residues.
Residues in food relates to the residual amount of a particular compound either administered to an animal as a veterinary treatment or a naturally occurring compound present in food for human consumption.
There are a number of potential issues that can arise from contaminated feed and it is important for producers to ensure that animal feed has little or no trace of residues of mycotoxins, growth promoters or veterinary drugs.
Veterinary drugs are often added to feed to be used as a method of treating livestock, producers therefore must be sure of the dosage to ensure that withdrawal periods are correctly adhered to. Mycotoxins may also be present in feed due to a number of environmental factors, this can have a negative impact of the livestock.
The Mycotoxin Threat
Mycotoxins are naturally occurring toxins produced by fungi, commonly known as moulds, which can have a harmful effect on humans and livestock. These moulds are of interest to producers because they have the potential for significant economic losses due to how they impact human health, animal productivity and international trading.
Mycotoxins can be present in a wide variety of foods and feeds and are a particular threat in areas with climates of high temperature and humidity. They can enter the food or feed chain through contaminated crops, in particular cereals, poultry meat and kidneys, pig kidneys and pork sausages. Contamination may also occur post-harvest during storage, transport, and processing stages of the food or feed supply chain.
The establishment of mycotoxin limits and regulations have been set by multiple food agencies worldwide. For example the EU 2002-32 Directive sets maximum permitted levels (MPLs) for substances that are present in, or on, animal feed that have the potential to pose danger to animal or human health, to the environment, or could have an undesirable affect to livestock production.
One type of livestock that can be significantly impacted by mycotoxins are pigs. Pig feed contaminated with mycotoxins can cause serious risks to pig health.
For example, Aflatoxins consumed by swine can expose non-clinical characteristics with low level exposure (20 to 200 ppb), inducing symptoms displayed such as feed avoidance, gastrointestinal disturbances, paleness and slower growth. It can also suppress the immune system and cause young piglets to become more susceptible to bacterial, viral or parasitic diseases. With prolonged exposure causing a greater risk of cancer, liver damage and jaundice. High concentrations of aflatoxin (1,000 to 5,000 ppb) result in acute effects, including death. It is a genotoxic carcinogen and suitably its levels have been set as low as realistically possible in complete feeding stuffs for pigs and poultry with a maximum content value of 0.02.
Zearalenone is another mycotoxin that can have a negative impact on livestock. Produced by a strain of Fusarium graminearum it has been listed under the Directive with a guidance value. It has an estrogeneous action and is significantly toxic to the reproductive system of animals with the potential to cause rectal and vaginal prolapses in gilts (young sows). Zearalenone has been allocated a suggested guidance value of 0.1ppm in complementary and complete feeding stuffs for piglets and gilts and 0.25ppm in feedstuffs for sows and fattening pigs.
With the risk from multiple Mycotoxins in animal feed it is important to be able to detect dangerous levels of each listed in the EU Directive in order to reduce instances of damage to animal health.
Growth Promoters
Growth promoters are often used in the meat industry to increase yield of livestock, an important tool considering the increased demand on quantity from the food chain. Some of these growth promoters however are known to have a negative impact on both animal and human health.
The presence of anabolic steroids including beta agonists such as Clenbuterol and Ractopamine, as well as other veterinary drugs is under a strict monitoring program in meat and animal feed to prevent these negative impacts.
Growth promoting drugs are used to induce weight but can have various health concerns such as such as hospitalisation with reversible symptoms of increased heart rate, muscular tremors, headache, nausea, fever, and chills.
The potential human health risks highlight the importance of complete food safety testing before a food product reaches the public.
Veterinary Drugs
Due to the nature of the conditions livestock is generally kept in, there is a high potential for infection and spread of viruses. Producers need to be aware and proactive in treating any veterinary disease that arises.
One such disease that can be an issue is coccidiosis which is a parasitic disease of the intestinal tract. This disease can be spread by contact with infected faeces, or the ingestion of infected tissues by other animals. Coccisiostats are potent drugs which are widely used within veterinary practice to treat coccidiosis, mainly in feed additives. Chickens are susceptible to at least 11 species of coccidia that causes coccidiosis therefore creating an importance to treat for. Coccisiostat residues that occur in high levels within food for human consumption can be unsafe and can have negative effects on pre-existing coronary conditions/diseases. These residues can pass through the meat tissue and eggs.
The Solution
With a variety of potential residues to be detected and a need for accurate results many producers are using Randox Food Diagnostics technology to carry out sample analysis.
With the development of the patented Biochip Array Technology Randox have consolidated the testing of multiple residues down to one sample which means time and cost saving for the meat industry. For example, with one Biochip a meat producer’s laboratory could test for 9 different growth promoter residues.
The technology centres on the Biochip, a 9mm2 ceramic chip which acts as the reaction well where samples are placed, requiring little technical expertise for preparation. Each chip is spotted with the antibodies required to detect the individual analytes being tested for and can accommodate up to 43 analytes. Food laboratories can then detect 43 different residues with one test.
The biochip works on the Evidence Investigator (Semi-Automated) and Evidence MultiSTAT(Automated) analysers. These analysers are used as the imaging stations for the biochips. Each spotted test site sends out a chemiluminescent signal which is detected by the analyser, processed, quantified and validated by the instrument software.
With a simple process, fast method and trusted results many of the world’s top meat producers are investing in Biochip Array Technology to ensure the safety and quality of their products.
For more information please contact us at: info@randoxfooddiagnostics.com.